Sulfaquinoxaline

DB11464

small molecule vet_approved

Deskripsi

Sulfaquinoxaline is a veterinary medicine which can be given to cattle and sheep to treat coccidiosis.It is available in Pakistan with Sanna Laboratories in combination with Amprolium and Vitamin K as potential treatment of coccidiosis.

Struktur Molekul 2D

Berat 300.336
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

113 Data
Nicotine The risk or severity of adverse effects can be increased when Sulfaquinoxaline is combined with Nicotine.
Mecamylamine The risk or severity of adverse effects can be increased when Sulfaquinoxaline is combined with Mecamylamine.
Pentolinium The risk or severity of adverse effects can be increased when Sulfaquinoxaline is combined with Pentolinium.
Trimethaphan The risk or severity of adverse effects can be increased when Sulfaquinoxaline is combined with Trimethaphan.
Hexamethonium The risk or severity of adverse effects can be increased when Sulfaquinoxaline is combined with Hexamethonium.
Cyclopentamine The risk or severity of adverse effects can be increased when Sulfaquinoxaline is combined with Cyclopentamine.
Methotrexate The protein binding of Methotrexate can be increased when combined with Sulfaquinoxaline.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfaquinoxaline.
Dexketoprofen The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Sulfaquinoxaline.
Cyclosporine The risk or severity of renal failure can be increased when Sulfaquinoxaline is combined with Cyclosporine.
Insulin human The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin human.
Insulin lispro The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin lispro.
Insulin glargine The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin glargine.
Insulin pork The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin pork.
Troglitazone The therapeutic efficacy of Troglitazone can be increased when used in combination with Sulfaquinoxaline.
Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfaquinoxaline.
Sulfisoxazole The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Sulfaquinoxaline.
Disopyramide The therapeutic efficacy of Disopyramide can be increased when used in combination with Sulfaquinoxaline.
Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Sulfaquinoxaline.
Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Sulfaquinoxaline.
Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Sulfaquinoxaline.
Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Sulfaquinoxaline.
Acetohexamide The therapeutic efficacy of Acetohexamide can be increased when used in combination with Sulfaquinoxaline.
Quinine The therapeutic efficacy of Quinine can be increased when used in combination with Sulfaquinoxaline.
Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Sulfaquinoxaline.
Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Sulfaquinoxaline.
Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Sulfaquinoxaline.
Pentamidine The therapeutic efficacy of Pentamidine can be increased when used in combination with Sulfaquinoxaline.
Mifepristone The therapeutic efficacy of Mifepristone can be increased when used in combination with Sulfaquinoxaline.
Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Sulfaquinoxaline.
Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Sulfaquinoxaline.
Phenformin The therapeutic efficacy of Phenformin can be increased when used in combination with Sulfaquinoxaline.
Sulfamethoxazole The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Sulfaquinoxaline.
Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfaquinoxaline.
Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfaquinoxaline.
Gliclazide The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfaquinoxaline.
Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Sulfaquinoxaline.
Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Sulfaquinoxaline.
Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfaquinoxaline.
Gliquidone The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfaquinoxaline.
Mitiglinide The therapeutic efficacy of Mitiglinide can be increased when used in combination with Sulfaquinoxaline.
Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Sulfaquinoxaline.
Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Sulfaquinoxaline.
Exenatide The therapeutic efficacy of Exenatide can be increased when used in combination with Sulfaquinoxaline.
Mecasermin The therapeutic efficacy of Mecasermin can be increased when used in combination with Sulfaquinoxaline.
Pramlintide The therapeutic efficacy of Pramlintide can be increased when used in combination with Sulfaquinoxaline.
Glisoxepide The therapeutic efficacy of Glisoxepide can be increased when used in combination with Sulfaquinoxaline.
Insulin aspart The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin aspart.
Insulin detemir The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin detemir.
Insulin glulisine The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin glulisine.
Glymidine The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfaquinoxaline.
AICA ribonucleotide The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Sulfaquinoxaline.
Buformin The therapeutic efficacy of Buformin can be increased when used in combination with Sulfaquinoxaline.
Vildagliptin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfaquinoxaline.
Voglibose The therapeutic efficacy of Voglibose can be increased when used in combination with Sulfaquinoxaline.
NN344 The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with NN344.
AMG-222 The therapeutic efficacy of AMG-222 can be increased when used in combination with Sulfaquinoxaline.
Bisegliptin The therapeutic efficacy of Bisegliptin can be increased when used in combination with Sulfaquinoxaline.
Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Sulfaquinoxaline.
Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Sulfaquinoxaline.
Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Sulfaquinoxaline.
Liraglutide The therapeutic efficacy of Liraglutide can be increased when used in combination with Sulfaquinoxaline.
Gosogliptin The therapeutic efficacy of Gosogliptin can be increased when used in combination with Sulfaquinoxaline.
Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Sulfaquinoxaline.
Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Sulfaquinoxaline.
Glibornuride The therapeutic efficacy of Glibornuride can be increased when used in combination with Sulfaquinoxaline.
Benfluorex The therapeutic efficacy of Benfluorex can be increased when used in combination with Sulfaquinoxaline.
Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Sulfaquinoxaline.
Albiglutide The therapeutic efficacy of Albiglutide can be increased when used in combination with Sulfaquinoxaline.
Dulaglutide The therapeutic efficacy of Dulaglutide can be increased when used in combination with Sulfaquinoxaline.
Lobeglitazone The therapeutic efficacy of Lobeglitazone can be increased when used in combination with Sulfaquinoxaline.
Netoglitazone The therapeutic efficacy of Netoglitazone can be increased when used in combination with Sulfaquinoxaline.
Rivoglitazone The therapeutic efficacy of Rivoglitazone can be increased when used in combination with Sulfaquinoxaline.
Ciglitazone The therapeutic efficacy of Ciglitazone can be increased when used in combination with Sulfaquinoxaline.
Lixisenatide The therapeutic efficacy of Lixisenatide can be increased when used in combination with Sulfaquinoxaline.
Insulin beef The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin beef.
Insulin degludec The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin degludec.
Insulin peglispro The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin peglispro.
Insulin tregopil The risk or severity of hypoglycemia can be increased when Sulfaquinoxaline is combined with Insulin tregopil.
Ipragliflozin The therapeutic efficacy of Ipragliflozin can be increased when used in combination with Sulfaquinoxaline.
Dutogliptin The therapeutic efficacy of Dutogliptin can be increased when used in combination with Sulfaquinoxaline.
Allicin The therapeutic efficacy of Allicin can be increased when used in combination with Sulfaquinoxaline.
Tofogliflozin The therapeutic efficacy of Tofogliflozin can be increased when used in combination with Sulfaquinoxaline.
Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Sulfaquinoxaline.
2,4-thiazolidinedione The therapeutic efficacy of 2,4-thiazolidinedione can be increased when used in combination with Sulfaquinoxaline.
Teneligliptin The therapeutic efficacy of Teneligliptin can be increased when used in combination with Sulfaquinoxaline.
Omarigliptin The therapeutic efficacy of Omarigliptin can be increased when used in combination with Sulfaquinoxaline.
Carmegliptin The therapeutic efficacy of Carmegliptin can be increased when used in combination with Sulfaquinoxaline.
Gemigliptin The therapeutic efficacy of Gemigliptin can be increased when used in combination with Sulfaquinoxaline.
Anagliptin The therapeutic efficacy of Anagliptin can be increased when used in combination with Sulfaquinoxaline.
Evogliptin The therapeutic efficacy of Evogliptin can be increased when used in combination with Sulfaquinoxaline.
Sotagliflozin The therapeutic efficacy of Sotagliflozin can be increased when used in combination with Sulfaquinoxaline.
Balaglitazone The therapeutic efficacy of Balaglitazone can be increased when used in combination with Sulfaquinoxaline.
Remogliflozin etabonate The therapeutic efficacy of Remogliflozin etabonate can be increased when used in combination with Sulfaquinoxaline.
Carbutamide The therapeutic efficacy of Carbutamide can be increased when used in combination with Sulfaquinoxaline.
Guar gum The therapeutic efficacy of Guar gum can be increased when used in combination with Sulfaquinoxaline.
Metahexamide The therapeutic efficacy of Metahexamide can be increased when used in combination with Sulfaquinoxaline.
Semaglutide The therapeutic efficacy of Semaglutide can be increased when used in combination with Sulfaquinoxaline.
Taspoglutide The therapeutic efficacy of Taspoglutide can be increased when used in combination with Sulfaquinoxaline.
Englitazone The therapeutic efficacy of Englitazone can be increased when used in combination with Sulfaquinoxaline.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 5430695
    Righter HF, Worthington JM, Zimmerman HE Jr, Mercer HD: Tissue-residue depletion of sulfaquinoxaline in poultry. Am J Vet Res. 1970 Jun;31(6):1051-4.
  • PMID: 451426
    Rutczynska-Skonieczna EM: Detection of sulfaquinoxaline residues in eggs. Rocz Panstw Zakl Hig. 1979;30(2):137-40.
  • PMID: 847331
    Rutczynska-Skonieczna EM: Detection of sulfaquinoxaline residues in poultry meat. Rocz Panstw Zakl Hig. 1977;28(1):59-63.
  • PMID: 5962189
    Kahn SG, Actor P: Enhancement of sulfaquinoxaline activity by nystatin. Poult Sci. 1966 May;45(3):581-2.
  • PMID: 7174488
    Brown MJ, Wojcik B, Burgess EC, Smith GJ: Adverse reactions to sulfaquinoxaline in coyote pups--. J Am Vet Med Assoc. 1982 Dec 1;181(11):1419-20.
  • PMID: 13349011
    Authors unspecified: VITAMIN K and sulfaquinoxaline poisoning in chickens. Nutr Rev. 1956 Aug;14(8):240-1.
  • PMID: 20265822
    MUSHETT CW, SEELER AO: Hypoprothrombinemia resulting from the administration of sulfaquinoxaline. J Pharmacol Exp Ther. 1947 Sep;91(1):84-91.
  • PMID: 13533778
    HAGEN KW Jr: The effects of continuous sulfaquinoxaline feeding on rabbit mortality. Am J Vet Res. 1958 Apr;19(71):494-6.
Menampilkan 8 dari 30 artikel.
Textbook
  • ISBN: 1584884169
    Yannai, Shmuel (2003). Dictionary of Food Compounds with : Additives, Flavors, and Ingredients. CRC Press LLC.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul